Hormone Sensitive Advanced Prostate Cancer Treatment Market Set to Soar at 7.2% CAGR, Exceeding US$ 24.94 Billion by 2033 | Says FMI
The global hormone-sensitive advanced prostate cancer treatment market is expected to be worth US$12.44 Billion in 2023.